Dr. Jun Bao 鲍军
Chief Physician
Department of Medical Oncology, Jiangsu Cancer Hospital, Nanjing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of precancerous gastrointestinal conditions and motility disorders, including atrophic gastritis, Helicobacter pylori infection, gastroesophageal reflux disease, peptic ulcer, ulcerative colitis, and radiation enteritis.
Dr. Bao is Chief Physician and President of Jiangsu Cancer Hospital. Dr. Bao earned a Bachelor of Clinical Medicine from Southeast University School of Medicine in 1998 and a PhD in Integrated Traditional Chinese and Western Medicine from Nanjing University of Chinese Medicine in 2007.
Professional roles
- Member, Chinese Medical Association
- Youth Committee Member, Health Management Professional Committee, Chinese Medical Association
- Committee Member, Epidemiology Group, Geriatrics Branch, Chinese Medical Association
- Vice Chair, Tumor Endoscopy Professional Committee, Jiangsu Anti-Cancer Association
Name order: in Chinese the family name comes first (Bao Jun). Papers usually list the name as Jun Bao or Bao J.
Selected publications
24 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- BMC Cancer, 2026 (senior author): Retraction Note: Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon. PubMed 42632895
- Front Immunol, 2026 (senior author): Clinical exploration of first-line therapy in metastatic lung adenocarcinoma patients with negative or low PD-L1 expression: a retrospective cohort study. PubMed 42317329
- Carbohydr Res, 2024 (senior author): Bile acid conjugated chitosan nanoparticles promote the proliferation and epithelial-mesenchymal transition of hepatocellular carcinoma by regulating the PI3K/Akt/mTOR pathway. PubMed 39471534
- Int J Surg, 2023 (senior author): Application and development of noninvasive biomarkers for colorectal cancer screening: a systematic review. PubMed 36974713
- Theranostics, 2021 (senior author): PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression. PubMed 33664859
- BMC Cancer, 2020 (senior author): Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon. PubMed 32345258
- Gastroenterol Res Pract, 2014 (first author): Rab27b is a potential predictor for metastasis and prognosis in colorectal cancer. PubMed 25580113
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion